Intellia Therapeutics Inc.
NTLA | NASDAQ
$12.62
+$0.40 (+3.27%)
Sep 22, 2026, 12:43 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -2.36 | -2.22 | -5.63 | -5.66 | -31.28 | -22.67 |
PEG Ratio | 0.09 | 0.71 | 0.47 | -0.09 | -0.54 | -1.01 |
PS Ratio | 14.40 | 19.91 | 74.61 | 51.53 | 253.61 | 52.52 |
PB Ratio | 1.45 | 1.32 | 2.58 | 2.17 | 8.06 | 5.78 |
P/FCF Ratio | -2.75 | -3.25 | -6.63 | -6.86 | -35.25 | -56.93 |
P/OCF Ratio | -2.79 | -3.30 | -6.87 | -8.06 | -37.25 | -61.02 |
OCF/S Ratio | -515.55 | -602.80 | -1.09K | -639.45 | -680.82 | -86.06 |
Debt / Equity Ratio | 0.14 | 0.24 | 0.11 | 0.11 | 0.07 | 0.07 |
Quick Ratio | 5.08 | 5.77 | 8.67 | 9.61 | 6.11 | 9.59 |
Current Ratio | 5.08 | 5.77 | 8.67 | 9.61 | 6.11 | 9.59 |
Asset Turnover | 0.08 | 0.05 | 0.03 | 0.03 | 0.03 | 0.09 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -61.47% | -59.52% | -45.82% | -38.38% | -25.75% | -25.47% |
Return on Assets | -49.01% | -43.58% | -36.99% | -31.19% | -20.70% | -19.85% |
Return on Invested Capital | -57.67% | -48.55% | -42.79% | -32.49% | -22.74% | -22.11% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 76.47% | 82.23% | 75.26% | 85.47% | 79.15% | -159.35% |
Net Profit Margin | -609.85% | -896.77% | -1.33K% | -909.78% | -810.49% | -231.46% |
Pretax Profit Margin | -609.85% | -896.77% | -1.33K% | -909.78% | -810.49% | -231.46% |
Operating Profit Margin | -651.67% | -923.10% | -1.42K% | -879.04% | -810.37% | -235.51% |
FCF Margin | -524.09% | -612.78% | -1.12K% | -751.48% | -719.41% | -92.25% |
EBITDA Margin | -586.32% | -879% | -1.3K% | -895.25% | -789.64% | -224.63% |
Add to Watchlist
Select watchlists to add or remove NTLA